This inventor holds 1 USPTO granted patent. Top assignee: Daiichi Pharmaceutical Co., Ltd.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Kenji Namba: Innovator in Antibacterial Agents
Introduction
Kenji Namba is a notable inventor based in Edogawa-ku, Japan. He has made significant contributions to the field of antibacterial agents, particularly focusing on compounds that combat acid-fast bacteria. His work is characterized by a commitment to improving pharmacological safety and efficacy.
Latest Patents
Kenji Namba holds a patent for an "Anti acid-fast bacterial agent containing pyridonecarboxylic acids as active ingredient." This innovative agent includes a pyridonecarboxylic acid derivative, which demonstrates excellent antibacterial activity against atypical acid-fast bacteria. The formulation also exhibits favorable pharmacokinetics and safety profiles, making it a valuable addition to antibacterial therapies.
Career Highlights
Throughout his career, Namba has been associated with Daiichi Pharmaceutical Co., Ltd., where he has focused on research and development in the pharmaceutical sector. His dedication to advancing medical science is evident in his patent work and contributions to the field.
Collaborations
Kenji Namba has collaborated with esteemed colleagues such as Makoto Takemura and Hisashi Takahashi. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Kenji Namba's work in developing antibacterial agents showcases his expertise and commitment to improving healthcare solutions. His contributions are vital in the ongoing battle against bacterial infections, particularly those caused by acid-fast bacteria.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile